Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Guy's and St Thomas' NHS Foundation Trust
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The Second Affiliated Hospital of Kunming Medical University
Zhongnan Hospital
RemeGen Co., Ltd.
SUNHO(China)BioPharmaceutical CO., Ltd.
Children's Memorial Health Institute, Poland
Alliance for Clinical Trials in Oncology
Shanxi Bethune Hospital
Sinocelltech Ltd.
Guangxi Medical University
Tang-Du Hospital
University of Malaya
Institute of Cancer Research, United Kingdom
Tanta University
Sheba Medical Center
Qilu Pharmaceutical Co., Ltd.
Beijing Tiantan Hospital
Ain Shams University
Third Affiliated Hospital, Sun Yat-Sen University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
National University Hospital, Singapore
Shanghai Pulmonary Hospital, Shanghai, China
Laibin People's Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Beni-Suef University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fudan University
THERABIONIC INC.
University of Birmingham
Peking Union Medical College Hospital
Taizhou Hospital
Qilu Pharmaceutical Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Miracogen Inc.
Zhejiang University
Cancer Hospital of Guangxi Medical University
Assiut University
Zhongda Hospital
Zhongda Hospital
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
The First Affiliated Hospital of Zhengzhou University
University of British Columbia
Beni-Suef University
Spanish Oncology Genito-Urinary Group
Tanta University
The First Affiliated Hospital of Soochow University
National Cancer Centre, Singapore